Michael Lukey Archives | ��ϳԹ��Դ

Lukey receives 2025 Stone Faculty Award

Lisa Cruz — Thu, 22 Jan 2026 19:00:00 +0000

��ϳԹ��Դ (CSHL) Associate Professor Michael Lukey is the recipient of the 2025 James M. and Cathleen D. Stone Faculty Award, an honor presented annually to an assistant or associate professor who has made a significant research contribution. Established by CSHL Trustee James M. Stone and his wife, Cathleen, the award recognizes accomplishments...

The post Lukey receives 2025 Stone Faculty Award appeared first on ��ϳԹ��Դ.

Inspiring breast cancer breakthroughs

Communications Department — Mon, 18 Aug 2025 17:30:23 +0000

Breast cancer is one of the most common cancers among women in the United States, second only to skin cancer. Thanks to decades of fundamental research, it’s also one of the most curable. However, challenges remain, especially when confronting aggressive varieties like triple-negative breast cancer. ��ϳԹ��Դ (CSHL) has a rich history of...

The post Inspiring breast cancer breakthroughs appeared first on ��ϳԹ��Դ.

Veronica Beard hosts CSHL–Penny’s Flight fundraiser

Caroline Cosgrove — Mon, 07 Apr 2025 16:00:45 +0000

Fashion and philanthropy came together to support crucial scientific research, as ��ϳԹ��Դ (CSHL) and the Penny’s Flight Foundation recently partnered with women’s designer clothing brand Veronica Beard for an exclusive in-person shopping event at the brand’s luxury storefront in Manhasset, NY. The event featured a sit-down discussion between CSHL’s Sarah Kitt and...

The post Veronica Beard hosts CSHL–Penny’s Flight fundraiser appeared first on ��ϳԹ��Դ.

How breast cancer goes hungry

Jennifer Michalowski — Wed, 28 Aug 2024 11:30:11 +0000

Cancer cells have voracious appetites. And there are certain nutrients they can’t live without. Scientists have long hoped they might stop tumors in their tracks by cutting off an essential part of cancer cells’ diet. But these cells are crafty and often find a new way to get what they need. How? By reprogramming their...

The post How breast cancer goes hungry appeared first on ��ϳԹ��Դ.

New hope in the fight against neurofibromatosis

Nick Wurm — Mon, 18 Mar 2024 11:30:31 +0000

It’s the most common single-gene neurological disorder in the world. It is typically diagnosed in children. It’s often accompanied by learning challenges. It can lead to tumors in the brain, spinal cord, and throughout the body. It’s called neurofibromatosis type 1 (NF1). One out of every 3,000 people is born with the disease. And there...

The post New hope in the fight against neurofibromatosis appeared first on ��ϳԹ��Դ.

Test your breast cancer awareness

Communications Department — Wed, 18 Oct 2023 11:30:33 +0000

{“questions”:{“equ3q”:{“id”:”equ3q”,”mediaType”:”image”,”answerType”:”text”,”imageCredit”:””,”image”:”https:\/\/www.cshl.edu\/wp-content\/uploads\/2019\/12\/novel-therapy-target-triple-negative-breast-cancer.jpg”,”imageId”:”36481″,”video”:””,”imagePlaceholder”:””,”imagePlaceholderId”:””,”title”:”Some breast cancers lack two key hormone receptors as well as the HER2 receptor. What is this type of breast cancer called?”,”desc”:”In triple-negative breast cancer, the cancer cells don\u2019t have estrogen, progesterone, or HER2 receptors. As a result, this kind of cancer is very difficult to treat. CSHL Professor John Moses and Assistant Professor Michael...

The post Test your breast cancer awareness appeared first on ��ϳԹ��Դ.

President’s essay: Bringing bold visions to life

Communications Department — Fri, 26 May 2023 11:30:08 +0000

The art of high-impact research, which is at the core of ��ϳԹ��Դ (CSHL), is to pursue important questions, follow unanticipated leads, and be bold in crafting new ideas. In this way, we challenge our researchers to move science into new frontiers. While our scientists have freedom to pursue their ideas, they are...

The post President’s essay: Bringing bold visions to life appeared first on ��ϳԹ��Դ.

A new, sustainable source for a promising cancer killer

Luis Sandoval — Thu, 23 Mar 2023 16:00:04 +0000

Tabernaemontana corymbosa, seen above, produces a natural cancer-killing molecule. Normally, you’d have to travel all the way to Malaysia to find it. Instead, CSHL chemists have recreated this cancer killer in the lab using sustainable chemistry techniques." data-description="" />Plants produce all types of curious chemicals. Some deter predators. Some smell wonderful. Some even have medicinal value. One of these hidden gems is (–)-jerantinine A (JA), a molecule with remarkable anticancer properties, produced by a plant called Tabernaemontana corymbosa. Unfortunately, access to this Malaysian jungle plant and its promising chemical compound has been limited....

The post A new, sustainable source for a promising cancer killer appeared first on ��ϳԹ��Դ.

How cancer metabolism could be key for new therapies

Sara Roncero-Menendez — Wed, 05 Feb 2020 14:00:54 +0000

Biochemist Michael Lukey joins ��ϳԹ��Դ (CSHL) as the newest addition to its National Cancer Institute-designated Cancer Center. Lukey studies the metabolic reprogramming events that cancer cells undergo to feed tumor growth. He works on identifying vulnerabilities in these metabolic processes that can be targets for cancer therapy, including when breast cancer metastasizes...

The post How cancer metabolism could be key for new therapies appeared first on ��ϳԹ��Դ.

Michael Lukey Archives | ���ϳԹ���Դ